Author: Abdul-Qadir

  • WHO to continue support for Chagas disease programme that promotes patient self-care

    The World Health Organization (WHO) and the Catalan Ministry of Health say they’ll collectively support the dissemination of a programme that gives support to sufferers affected by Chagas disease to handle their very own well being and promote self-care.

    The Catalonian ‘Expert Patient Programme on Chagas disease’ includes interplay and sharing of knowledge amongst individuals affected by the disease and is performed by an knowledgeable patient. The programme is taken into account to have completed very properly because it was first initiated in 2017.

    “Over the previous few years we now have seen exceptional improve in consciousness and confidence amongst sufferers to pursue medical care and follow-up with physicians” stated Dr Pedro Albajar Vinas, who’s accountable for WHO’s Chagas disease programme. “When sufferers discuss to each other there may be higher deal with general perceptions of well being, life-style, bettering shallowness, self-care and particular person satisfaction.”

    The programme additionally encourages self-responsibility and features as a part of the Chronic Disease Prevention and Care Programme of the Government of Catalonia. It is predicated on three key approaches:

    • support supplied by sufferers and observing professionals to these in power part of the disease;
    • promote interplay in teams by 9 fastidiously deliberate periods;
    • consider efficiency of previous periods by questionnaires earlier than a brand new session begins.

    Many individuals who attended the programme over time say they might suggest it to household and associates because it vastly helps to enhance information about disease.

    Initiators of the programme are assured that the methodology used, and classes discovered can type a part of a broader technique to push for complete care for a disease that continues to be largely uncared for. For instance, regardless of the efforts of the previous decade, the worldwide detection fee for Chagas disease is lower than 10%.

    Through this settlement, WHO will present support in facilitating the interpretation of supplies and paperwork in languages utilized in its Member States in addition to help within the improvement of any mobile-based software if the necessity arises. The Government of Catalonia will print and distribute for advocacy functions.

    To promote international advocacy for the disease, the World Health Assembly – WHO’s decision-making physique – in 2019 adopted a call to have a good time World Chagas Disease Day on 14 April.

    The disease

    Chagas disease was as soon as confined to rural areas of Latin American international locations the place the primary route of transmission is vectorial transmission.

    But over the previous many years, the disease has been more and more reported in lots of international locations exterior Latin America primarily due to motion of populations and migration.

    According to WHO estimates, round 6-7 million individuals are contaminated with Trypanosoma cruzi – the protozoan parasite that causes Chagas disease.

    Vectorial transmission happens when people are available in contact with the faeces or urine of triatomine bugs (referred to as ‘kissing bugs’, amongst many different native names).

    These bugs – the vectors that carry the parasites – reside within the wall or roof cracks of properties – the place they disguise in the course of the day and lively at evening after they feed on human blood. They often chew an uncovered space of pores and skin such because the face (therefore its widespread identify ‘kissing bug’).

    Right after a chew, the bug defecates/urinates shut to the chew space. The parasites enter the physique when the particular person instinctively reacts to the chew and smears the bug faeces or urine into the chew, the eyes, the mouth, or into any pores and skin break.

    The parasite may also be transmitted by:

    • consumption of meals contaminated with T. cruzi by, for instance, contact with faeces or urine of contaminated triatomine bugs or marsupials (this type of transmission sometimes causes outbreaks with extra extreme morbidity and better mortality – infecting teams of individuals concurrently with extra frequent instances of extreme disease and better variety of deaths);
    • blood or blood product transfusion from contaminated donors;
    • passage from an contaminated mom to her new child throughout being pregnant or childbirth;
    • some organ transplants utilizing organs from contaminated donors; and
    • laboratory accidents.

    There is not any vaccine in opposition to Chagas disease. Domiciliary vectorial management and transfusional management, along with congenital transmission, stay the simplest strategies of stopping transmission in Latin America.

    Chagas disease was named after Carlos Ribeiro Justiniano Chagas, a Brazilian doctor and researcher who found the disease in 1909.

    WHO to continue support for Chagas disease programme that promotes patient self-care
    Read More
    https://www.who.int/news-room/detail/29-03-2020-who-to-continue-support-for-chagas-disease-programme-that-promotes-patient-self-care

    Views: 0

  • World Health Worker Week – April  5 – 11, 2020

    The COVID-19 pandemic and different international emergencies present us as soon as once more the heroic efforts well being staff on the entrance traces make day-after-day to maintain their communities—and the world—protected and wholesome.  The WHO and the Global Health Workforce Network is happy to associate with civil society companions—the Frontline Health Workers Coalition and its members—to honor well being staff throughout World Health Worker Week: April 5-11, 2020. The Eighth Annual World Health Worker Week is yet one more alternative to mobilize communities, companions, and policymakers to extend assist of well being staff worldwide.

    The 2020 theme is Leaders on the Front Line. This theme highlights the want to offer higher management alternatives for frontline well being staff—significantly ladies well being staff, who make up greater than 70% of the worldwide well being workforce. At the identical time, this theme emphasizes how well being staff usually put themselves on the road, usually at nice private danger to themselves and their households, to avoid wasting and enhance lives.

    We invite all well being workforce stakeholders to affix us by elevating public consciousness and fascinating on well being workforce points, and acknowledge the lifesaving contribution of the well being workforce. All actions can be filtered by a World Health Worker Week portal, hosted by the Frontline Health Workers Coalition secretariat at IntraHealth International.

     Some key methods to get entangled:

    • Add your voice to the #WHWWeek dialog on social media! Use the WHWW Social Media Guide with key messages, graphics, and steered tweets.
    • Participate within the WHWW Video Testimonial Series and inform well being policymakers why frontline well being staff are Leaders on the Line and the way we will higher assist them. It’s straightforward to participate—see the guidance and add your video.
    • Celebrate World Health Day on Tuesday, April 7. In this International Year of the Nurse and the Midwife, World Health Day will shine a lightweight on the important function nurses and midwives play in offering well being care world wide, and name for a strengthening of the nursing and midwifery workforce. Share and promote World Health Day belongings here.

     

     

    World Health Worker Week - April  5 - 11, 2020
    Read More
    https://www.who.int/news-room/detail/02-04-2020-world-health-worker-week-2020

    Views: 0

  • WHO to accelerate action to reduce the harmful use of alcohol

    The
    harmful use of alcohol causes roughly Three million deaths yearly and the
    general burden of illness and accidents attributable to alcohol consumption
    stays unacceptably excessive. The tempo of improvement and implementation of
    alcohol insurance policies has been uneven in WHO areas, and assets and capacities
    for implementation of the WHO Global technique to reduce the harmful use of
    alcohol 10 years after its endorsement don’t correspond to the magnitude of
    the issues. On this foundation, the WHO Executive Board in its choice EB146
    (14)
     known as for accelerated action to reduce the harmful use of
    alcohol. 

    The Board thought of the report on the political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases, notably Annex 3, entitled “Implementation of the global strategy to reduce the harmful use of alcohol,” and the report on the findings of the consultative process on implementation of the global strategy to reduce the harmful use of alcohol and the way forward.

    The Board, in its choice EB146 (14),  requested  the WHO Director-General, inter alia, “to develop an action plan (2022-2030) to effectively implement the Global strategy to reduce the harmful use of alcohol as a public health priority, in consultation with Member States and relevant stakeholders, for consideration by the 75th World Health Assembly through the 150th session of the WHO Executive Board in 2022”, and “to develop a technical report on the harmful use of alcohol related to cross-border alcohol marketing, advertising and promotional activities, including targeting youth and adolescents, before the 150th session of the WHO Executive Board, which could contribute to the development of the action plan”,  in addition to “to adequately useful resource the work on the harmful use of alcohol.

    In response to choice EB146 (14), the WHO Secretariat will implement the following:

    • March– April 2020: Commissioning of the scoping evaluate on the harmful use of alcohol associated to cross-border alcohol advertising and marketing, promoting and promotional actions, together with concentrating on youth and adolescents.  Commissioning background papers for the report improvement. 
    • ­April-May 2020: Producing zero draft of the working doc for improvement of an action plan (2022-2030) to successfully implement the Global technique to reduce the harmful use with proposed important parts and parts.  
    • ­June 2020: Technical professional conferences organized by WHO headquarters to talk about zero draft of the working doc for improvement of the action plan and the content material of the technical report on the harmful use of alcohol associated to cross-border alcohol advertising and marketing, promoting and promotional actions.  
    • ­July-September 2020: Finalization of the working doc for subsequent session course of. Web-based session on the working doc for improvement of the action plan open to Member States, UN organizations and different worldwide organizations, and non-State actors. All related suggestions acquired will probably be revealed on WHO web site. 
    • ­October 2020 – March 2021: Regional technical consultations with Member States on the working doc for improvement of the action plan (2022-2030). 
    • ­March– April 2021: Development of the first draft of the action plan primarily based on the enter acquired on the working doc in the course of of the regional consultations.
    • April -June 2021: The web-based session on the first draft of the action plan open to Member States, UN organizations and different worldwide organizations, and non-State actors.  All related suggestions acquired will probably be revealed on WHO web site. Discussion of the first draft at the Third WHO Forum on alcohol, medication and addictive behaviours attended by technical focal factors from Member States, representatives of UN entities, civil society organizations, WHO collaborating centres, and academia. Consultation with financial operators in alcohol manufacturing and commerce on their contribution to decreasing the harmful use of alcohol inside their core roles.  An casual session with Member States on the first draft of the action plan.
    • ­July-August 2021: Development of the second draft of the action plan primarily based on the suggestions acquired on the first draft throughout the earlier levels of the session course of. 
    • ­August-November 2021: Briefings on the second draft of the action plan organized at the Regional Committee conferences.  Release of the technical report on the harmful use of alcohol associated to cross-border alcohol advertising and marketing, promoting and promotional actions, together with concentrating on youth and adolescents, with a abstract of fundamental findings and conclusions out there in six languages.  A proper assembly of Member States for consideration of the second draft of the action plan. Finalization of the draft action plan considered suggestions and inputs acquired from Member States and different stakeholders throughout the session course of in April -October 2021.  Development and submission of the report by the Secretariat to 150th session of the Executive Board. 
    • ­January/February 2022: The 150th session of the WHO Executive Board will think about the report of the WHO Director-General containing the draft action plan (2022-2030) to successfully implement the Global technique to reduce the harmful use of alcohol.

     

    WHO to accelerate action to reduce the harmful use of alcohol
    Read More
    https://www.who.int/news-room/detail/28-03-2020-who-to-accelerate-action-to-reduce-the-harmful-use-of-alcohol

    Views: 0

  • Medical Product Alert N°3/2020

    This Medical Product Alert warns consumers, healthcare professionals, and health authorities against a growing number of falsified medical products that claim to prevent, detect, treat or cure COVID-19. 

    The Coronavirus disease (COVID-19) pandemic (caused by the virus SARS-CoV-2) has increased demand for medicines, vaccines, diagnostics and reagents, all related to COVID-19, creating an opportunity for ill-intended persons to distribute falsified medical products 

    Due diligence is required from all actors in the procurement, use and administration of medical products, in particular those affected by the current crisis of, or related to, COVID-19. 

    1. FALSIFIED IN VITRO DIAGNOSTICS AND LABORATORY REAGENTS 

    WHO has received multiple reports regarding falsified in vitro diagnostics (IVDs) and laboratory reagents for the detection of SARS-CoV-2. Please refer to WHO’s Emergency Use Listing for a list of diagnostics approved for clinical use by WHO. To date, eight countries (Australia, Brazil, Canada, PR China, Russian Federation, Singapore, Republic of Korea, United States of America) have listed IVDs for COVID-19 diagnosis based on expedited regulatory assessments. Please note that, in the European Union, regulatory compliance for SARS-CoV-2 diagnostics are self-declared by the manufacturer.  

    To assist Member States and stakeholders, WHO has published the links to these emergency lists, together with contact details. These links provide information on IVDs authorized for use in the jurisdictions of the International Medical Device Regulators Forum, as well as policies and guidance. WHO will provide updated versions as new information becomes available.

    End-users are encouraged to check the labelling against the information posted by regulatory authorities upon listing to ensure they are in possession of the genuine product. This information might include product name, product code, expiry date, instructions for use and manufacturer details. 

    Unregulated websites supplying medicines and/or vaccines, particularly those concealing their physical address or landline telephone number, are frequently the source of unlicensed, substandard and falsified medical products. WHO has been made aware of various unregistered websites claiming that products on sale can treat or prevent COVID-19. Such products are likely to be falsified medicines. In addition, some websites may appear to provide easy access to legitimate medicines that are otherwise not readily available. End-buyers and consumers should be especially wary of such online scams and exert due diligence when purchasing any medical product, whether online or not.

     2. FALSIFIED MEDICINES AND VACCINES

    At this stage, WHO does not recommend any medicines to treat or cure COVID-19. However, the SOLIDARITY trial, led by WHO, is reviewing potential treatments for COVID-19. 

    WHO requests increased vigilance from national health authorities, healthcare professionals, members of the public and supply chain stakeholders worldwide to prevent the distribution of these falsified medical products. Increased vigilance should focus on hospitals, clinics, health centres, clinical laboratories, wholesalers, distributors, pharmacies and any other suppliers of medical products. All medical products must be obtained from authentic and reliable sources. Their authenticity and condition of the product should be carefully checked. Consumers are advised to seek advice from a healthcare professional in case of doubt. 

    National health authorities are requested to immediately notify WHO if these falsified products are discovered in their country. If you have any information concerning the manufacture, distribution, or supply of these products, please contact rapidalert@who.int

    WHO Global Surveillance and Monitoring System for Substandard and Falsified Medical Products
    For further information, please visit our website: https://www.who.int/medicines/regulation/ssffc/en/ 

    Read More
    https://www.who.int/news-room/detail/31-03-2020-medical-product-alert-n-3-2020

    Views: 0

  • Are people living with HIV at increased risk of being infected with the virus that causes COVID-19?

    Are people living with HIV at increased risk of being infected with the virus that causes COVID-19?

    People living with HIV with advanced disease, those with low CD4 and high viral load and those who are not taking antiretroviral treatment have an increased risk of infections and related complications in general.  It is unknown if the immunosuppression of HIV will put a person at greater risk for COVID-19, thus, until more is known, additional precautions for all people with advanced HIV or poorly controlled HIV, should be employed

    At present there is no evidence that the risk of infection or complications of COVID-19 is different among people living with HIV who are clinically and immunologically stable on antiretroviral treatment when compared with the general population.  Some people living with HIV may have known risk factors for COVID-19 complications, such as diabetes, hypertension and other noncommunicable diseases and as such may have increased risk of COVID-19 unrelated to HIV.  We know that during the SARS and MERS outbreaks there were only a few case reports of mild disease among people living with HIV.

    To date, there is a case report of a person living with HIV who had COVID-19 and recovered and a small study on risk factors and antiretrovirals used among people living with HIV with COVID-19 from China.  This study reported similar rates of COVID-19 disease as compared to the entire population and increased risk with older age, but not with low CD4, high viral load level or antiretroviral regimen[4]. Current clinical data suggest the main mortality risk factors are linked to older age and other comorbidities including cardiovascular disease, diabetes, chronic respiratory disease, and hypertension. Some very healthy people have also developed severe disease from the coronavirus infection

    PLHIV are advised to take the same precautions as the general population

    • wash hands often
    • cough etiquette
    • physical distancing
    • seek medical care if symptomatic
    • self-isolation if in contact with someone with COVID-19 and
    • other actions per the government response

    People living with HIV who are taking antiretroviral drugs should ensure that they have at least 30 days and up to 6-month supply of medicines and ensure that their vaccinations are up to date (influenza and pneumococcal vaccines). Adequate supplies of medicines to treat co-infections and comorbidities and addiction should also be ensured.

    Views: 0

  • Joint Statement by QU Dongyu, Tedros Adhanom Ghebreyesus and Roberto Azevedo, Directors-General of the Food and Agriculture Organization of the United Nations (FAO), the World Health Organization (WHO) and the World Trade Organization (WTO)

    Millions of people around the world depend on international trade for their food security and livelihoods. As countries move to enact measures aiming to halt the accelerating COVID-19 pandemic, care must be taken to minimise potential impacts on the food supply or unintended consequences on global trade and food security. 

    When acting to protect the health and well-being of their citizens, countries should ensure that any trade-related measures do not disrupt the food supply chain. Such disruptions including hampering the movement of agricultural and food industry workers and extending border delays for food containers, result in the spoilage of perishables and increasing food waste. Food trade restrictions could also be linked to unjustified concerns on food safety. If such a scenario were to materialize, it would disrupt the food supply chain, with particularly pronounced consequences for the most vulnerable and food insecure populations. 

    Uncertainty about food availability can spark a wave of export restrictions, creating a shortage on the global market. Such reactions can alter the balance between food supply and demand, resulting in price spikes and increased price volatility. We learned from previous crises that such measures are particularly damaging for low-income, food-deficit countries and to the efforts of humanitarian organizations to procure food for those in desperate need.

    We must prevent the repeat of such damaging measures. It is at times like this that more, not less, international cooperation becomes vital. In the midst of the COVID-19 lockdowns, every effort must be made to ensure that trade flows as freely as possible, specially to avoid food shortage. Similarly, it is also critical that food producers and food workers at processing and retail level are protected to minimise the spread of the disease within this sector and maintain food supply chains. Consumers, in particular the most vulnerable, must continue to be able to access food within their communities under strict safety requirements.  

    We must also ensure that information on food-related trade measures, levels of food production, consumption and stocks, as well as on food prices, is available to all in real time. This reduces uncertainty and allows producers, consumers and traders to make informed decisions. Above all, it helps contain ‘panic buying’ and the hoarding of food and other essential items.

    Now is the time to show solidarity, act responsibly and adhere to our common goal of enhancing food security, food safety and nutrition and improving the general welfare of people around the world.  We must ensure that our response to COVID-19 does not unintentionally create unwarranted shortages of essential items and exacerbate hunger and malnutrition.

    Read More
    https://www.who.int/news-room/detail/30-03-2020-joint-statement-by-qu-dongyu-tedros-adhanom-ghebreyesus-and-roberto-azevedo-directors-general-of-the-food-and-agriculture-organization-of-the-united-nations-(fao)-the-world-health-organization-(who)-and-the-world-trade-organization-(wto)

    Views: 0

  • OHCHR, IOM, UNHCR and WHO joint press release: the rights and health of refugees, migrants and stateless must be protected in COVID-19 response

    In the face of the COVID-19 crisis, we are all vulnerable. The virus has shown that it does not discriminate – but many refugees, those forcibly displaced, the stateless and migrants are at heightened risk. 

    Three-quarters of the world’s refugees and many migrants are hosted in developing regions where health systems are already overwhelmed and under-capacitated.  Many live in overcrowded camps, settlements, makeshift shelters or reception centers, where they lack adequate access to health services, clean water and sanitation. 

    The situation for refugees and migrants held in formal and informal places of detention, in cramped and unsanitary conditions, is particularly worrying. Considering the lethal consequences a COVID-19 outbreak would have, they should be released without delay. Migrant children and their families and those detained without a sufficient legal basis should be immediately released.

    This disease can be controlled only if there is an inclusive approach which protects every individual’s rights to life and health.  Migrants and refugees are disproportionately vulnerable to exclusion, stigma and discrimination, particulary when undocumented.  To avert a catastrophe, governments must do all they can to protect the rights and the health of everyone. Protecting the rights and the health of all people will in fact help control the spread of the virus.

    It is vital that everyone, including all migrants and refugees, are ensured equal access to health services and are effectively included in national responses to COVID-19, including prevention, testing and treatment. Inclusion will help not only to protect the rights of refugees and migrants, but will also serve to protect public health and stem the global spread of COVID-19.  While many nations protect and host refugee and migrant populations, they are often not equipped to respond to crises such as Covid-19. To ensure refugees and migrants have adequate access to national health services, States may need additional financial support. This is where the world’s financial institutions can play a leading role in making funds available. 

    While countries are closing their borders and limiting cross-border movements, there are ways to manage border restrictions in a manner which respects international human rights and refugee protection standards, including the principle of non-refoulement, through quarantine and health checks. 

    More than ever, as COVID-19 poses a global threat to our collective humanity, our primary focus should be on the preservation of life, regardless of status.  This crisis demands a coherent, effective international approach that leaves no-one behind.  At this crucial moment we all need to rally around a common objective, fighting this deadly virus. Many refugees, displaced, stateless people and migrants have skills and resources that can also be part of the solution.

    We cannot allow fear or intolerance to undermine rights or compromise the effectiveness of responses to the global pandemic. We are all in this together. We can only defeat this virus when each and every one of us is protected. 

    Read More
    https://www.who.int/news-room/detail/31-03-2020-ohchr-iom-unhcr-and-who-joint-press-release-the-rights-and-health-of-refugees-migrants-and-stateless-must-be-protected-in-covid-19-response

    Views: 0

  • Medical Product Alert N°2/2020

    Medical Product Alert N°2/2020

    This Medical Product Alert relates to a confirmed falsified human immunodeficiency virus (HIV) in vitro diagnostic medical device (IVD) that has been identified circulating in Guyana and Kenya.

    Through its Global Surveillance and Monitoring System (GSMS) for substandard/falsified medical products,
    WHO was informed that at least 8,240 falsified rapid diagnostic tests to detect HIV-1/2 have been distributed in Guyana at end-user level. The product is Uni-Gold™ HIV and claims to be manufactured by
    Trinity Biotech plc. Subsequent reports
    revealed that the same falsified product is also circulating in Kenya.

    Uni-Gold™ HIV is a single-use rapid diagnostic test – an immunoassay for the qualitative detection of antibodies to HIV-1 and HIV-2 in serum, plasma and whole blood. Uni-Gold™ HIV is intended for use in point of care settings as an aid
    in diagnosis of HIV-1 and HIV-2 infection.

    The WHO testing strategy recommends three HIV reactive test results to confirm an HIV-positive status in a
    patient. The use of this falsified Uni-Gold™ HIV, subject of WHO medical product alert n°2 of 2020, is likely to lead to delayed diagnosis of HIV status.

    Table 1: Specific details of the falsified product Uni-Gold™ HIV, subject of WHO Medical Product Alert n°2 of 2020

    Product Name

    Uni-Gold™ HIV

    Lot Number

    HIV7120026

    Expiry Date

    5 DEC 2020

    Stated manufacturer

    Trinity Biotech

    The packaging of this falsified HIV test kit is in English.

    The genuine manufacturer (Trinity Biotech plc) has confirmed that:

    • They did not manufacture the falsified product in Table 1.
    • Genuine lot HIV7120026 was made by Trinity Biotech plc and expired in 2019.
    • The expiry date is incorrect and does not correspond with their batch manufacturing records.

    Photographs and advice to the public are available below.

    Figure 1 – Falsified Uni-Gold™ HIV, lot number HIV7120026, displaying falsified expiry date

     

    Falsified UniGold HIV Images 1 and 2 Alert

    Figure 2 – Falsified Uni-Gold™ HIV, displaying labelling inconsistencies

    Falsified UniGold HIV Image 3 Alert

     

    Advice on action to be taken by end-users:

    • Please check to see if any Uni-Gold™ HIV test kits in your facility have lot number HIV7120026.
    • If you are in possession of these falsified test kits with lot number HIV7120026:
    1. Please do not use.
    2. Please immediately contact the organization that supplied you with the product (either your HIV testing programme, nongovernmental organization or local distributor).
    3. Please contact Trinity Biotech plc

    Phone : +353 1 276 9800

    E-mail : hiv@trinitybiotech.com

    1. Please contact your national health authorities

    All medical products must be obtained from authentic and reliable sources. Their authenticity and condition should be carefully checked.

    Advice on action to be taken by national health authorities:

    WHO requests increased scrutiny within the supply chains of all countries, particularly at testing sites (health facilities, community-based), clinical laboratories, medical stores/warehouses, and at the facilities of relevant economic operators (agents,
    authorized representatives, distributors, wholesalers, etc.).

    If these falsified test kits with lot number HIV7120026 are discovered, please do not use.

    National health authorities are asked to immediately inform WHO, if these falsified products are discovered in their country using the WHO IVD complaint form.

    If you have any information concerning the manufacture, distribution, or supply of this product, please contact rapidalert@who.int

     

    WHO Global Surveillance and Monitoring System for Substandard and Falsified Medical Products

    For further information, please visit our website: https://www.who.int/medicines/regulation/ssffc/en/ 
     

    Medical Product Alert N°2/2020
    Read More
    https://www.who.int/news-room/detail/27-03-2020-medical-product-alert-n-2-2020

    Views: 0

  • PRESIDENT MUHAMMADU BUHARI’ ADDRESS ON THE COVID- 19 PANDEMIC

    PRESIDENT MUHAMMADU BUHARI’ ADDRESS ON THE COVID- 19 PANDEMIC

    ADDRESS BY H.E. MUHAMMADU BUHARI, PRESIDENT OF THE FEDERAL REPUBLIC OF NIGERIA ON THE COVID- 19 PANDEMIC SUNDAY 29TH MARCH, 2020

    1. Fellow Nigerians,

    2. From the first signs that Coronavirus, or COVID-19 was turning into an epidemic and was officially declared a world-wide emergency, the Federal Government started planning preventive, containment and curative measures in the event the disease hits Nigeria.

    3. The whole instruments of government are now mobilized to confront what has now become both a health emergency and an economic crisis.

    4. Nigeria, unfortunately, confirmed its first case on 27th February 2020. Since then, we have seen the number of confirmed cases rise slowly.

    5. By the morning of March 29th, 2020, the total confirmed cases within Nigeria had risen to ninety-seven.

    6. Regrettably, we also had our first fatality, a former employee of PPMC, who died on 23rd March 2020. Our thoughts and prayers are with his family in this very difficult time. We also pray for quick recovery for those infected and undergoing treatment.

    7. As of today, COVID-19 has no cure. Scientists around the world are working very hard to develop a vaccine.

    8. We are in touch with these institutions as they work towards a solution that will be certified by international and local medical authorities within the shortest possible time.

    9. For now, the best and most efficient way to avoid getting infected is through regular hygienic and sanitary practices as well as social distancing.

    10. As individuals, we remain the greatest weapon to fight this pandemic. By washing our hands regularly with clean water and soap, disinfecting frequently used surfaces and areas, coughing into a tissue or elbow and strictly adhering to infection prevention control measures in health facilities, we can contain this virus.

    11. Since the outbreak was reported in China, our Government has been monitoring the situation closely and studying the various responses adopted by other countries.

    12. Indeed, the Director General of the Nigeria Centre for Disease Control (NCDC) was one of ten global health leaders invited by the World Health Organisation to visit China and understudy their response approach. I am personally very proud of Dr Ihekweazu for doing this on behalf of all Nigerians.

    13. Since his return, the NCDC has been implementing numerous strategies and programs in Nigeria to ensure that the adverse impact of this virus on our country is minimized. We ask all Nigerians to support the work the Federal Ministry of Health and NCDC are doing, led by the Presidential Task Force.

    14. Although we have adopted strategies used globally, our implementation programs have been tailored to reflect our local realities.

    15. In Nigeria, we are taking a two step approach.

    16. First, to protect the lives of our fellow Nigerians and residents living here and second, to preserve the livelihoods of workers and business owners to ensure their families get through this very difficult time in dignity and with hope and peace of mind.

    17. To date, we have introduced healthcare measures, border security, fiscal and monetary policies in our response. We shall continue to do so as the situation unfolds.

    18. Some of these measures will surely cause major inconveniences to many citizens. But these are sacrifices we should all be willing and ready to make for the greater good of our country.

    19. In Nigeria’s fight against COVID-19, there is no such thing as an overreaction or an under reaction. It is all about the right reaction by the right agencies and trained experts.

    20. Accordingly, as a Government, we will continue to rely on guidance of our medical professionals and experts at the Ministry of Health, NCDC and other relevant agencies through this difficult time.

    21. I therefore urge all citizens to adhere to their guidelines as they are released from time to time.

    22. As we are all aware, Lagos and Abuja have the majority of confirmed cases in Nigeria. Our focus therefore remains to urgently and drastically contain these cases, and to support other states and regions in the best way we can.

    23. This is why we provided an initial intervention of fifteen billion Naira (N15b) to support the national response as we fight to contain and control the spread.

    24. We also created a Presidential Task Force (PTF) to develop a workable National Response Strategy that is being reviewed on a daily basis as the requirements change. This strategy takes international best practices but adopts them to suit our unique local circumstances.

    25. Our goal is to ensure all States have the right support and manpower to respond immediately.

    26. So far, in Lagos and Abuja, we have recruited hundreds of ad-hoc staff to man our call centers and support our tracing and testing efforts.

    27. I also requested, through the Nigeria Governors Forum, for all State Governments to nominate Doctors and Nurses who will be trained by the NCDC and Lagos State Government on tactical and operational response to the virus in case it spreads to other states.

    28. This training will also include medical representatives from our armed forces, paramilitary and security and intelligence agencies.

    29. As a nation, our response must be guided, systematic and professional. There is a need for consistency across the nation. All inconsistencies in policy guidelines between Federal and State agencies will be eliminated.

    30. As I mentioned earlier, as at this morning we had ninety-seven confirmed cases. Majority of these are in Lagos and Abuja. All the confirmed cases are getting the necessary medical care.

    31. Our agencies are currently working hard to identify cases and people these patients have been in contact with.

    32. The few confirmed cases outside Lagos and Abuja are linked to persons who have travelled from these centres.

    33. We are therefore working to ensure such inter state and intercity movements are restricted to prevent further spread.

    34. Based on the advice of the Federal Ministry of Health and the NCDC, I am directing the cessation of all movements in Lagos and the FCT for an initial period of 14 days with effect from 11pm on Monday, 30th March 2020. This restriction will also apply to Ogun State due to its close proximity to Lagos and the high traffic between the two States.

    35. All citizens in these areas are to stay in their homes. Travel to or from other states should be postponed. All businesses and offices within these locations should be fully closed during this period.

    36. The Governors of Lagos and Ogun States as well as the Minister of the FCT have been notified. Furthermore, heads of security and intelligence agencies have also been briefed.

    37. We will use this containment period to identify, trace and isolate all individuals that have come into contact with confirmed cases. We will ensure the treatment of confirmed cases while restricting further spread to other States.

    38. This order does not apply to hospitals and all related medical establishments as well as organizations in health care related manufacturing and distribution.

    39. Furthermore, commercial establishments such as;

    a. food processing, distribution and retail companies;

    b. petroleum distribution and retail entities,

    c. power generation, transmission and distribution companies; and

    d. private security companies are also exempted.

    40. Although these establishments are exempted, access will be restricted and monitored.

    41. Workers in telecommunication companies, broadcasters, print and electronic media staff who can prove they are unable to work from home are also exempted.

    42. All seaports in Lagos shall remain operational in accordance with the guidelines I issued earlier. Vehicles and drivers conveying essential cargoes from these Ports to other parts of the country will be screened thoroughly before departure by the Ports Health Authority.

    43. Furthermore, all vehicles conveying food and other essential humanitarian items into these locations from other parts of the country will also be screened thoroughly before they are allowed to enter these restricted areas.

    44. Accordingly, the Hon. Minister of Health is hereby directed to redeploy all Port Health Authority employees previously stationed in the Lagos and Abuja Airports to key roads that serve as entry and exit points to these restricted zones.

    45. Movements of all passenger aircraft, both commercial and private jets, are hereby suspended. Special permits will be issued on a needs basis.

    46. We are fully aware that such measures will cause much hardship and inconvenience to many citizens. But this is a matter of life and death, if we look at the dreadful daily toll of deaths in Italy, France and Spain.

    47. However, we must all see this as our national and patriotic duty to control and contain the spread of this virus. I will therefore ask all of us affected by this order to put aside our personal comfort to safeguard ourselves and fellow human beings. This common enemy can only be controlled if we all come together and obey scientific and medical advice.

    48. As we remain ready to enforce these measures, we should see this as our individual contribution in the war against COVID-19. Many other countries have taken far stricter measures in a bid to control the spread of the virus with positive results.

    49. For residents of satellite and commuter towns and communities around Lagos and Abuja whose livelihoods will surely be affected by some of these restrictive measures, we shall deploy relief materials to ease their pains in the coming weeks.

    50. Furthermore, although schools are closed, I have instructed the Ministry of Humanitarian Affairs, Disaster Management and Social Development to work with State Governments in developing a strategy on how to sustain the school feeding program during this period without compromising our social distancing policies. The Minister will be contacting the affected States and agree on detailed next steps.

    51. Furthermore, I have directed that a three month repayment moratorium for all TraderMoni, MarketMoni and FarmerMoni loans be implemented with immediate effect.

    52. I have also directed that a similar moratorium be given to all Federal Government funded loans issued by the Bank of Industry, Bank of Agriculture and the Nigeria Export Import Bank.

    53. For on-lending facilities using capital from international and multilateral development partners, I have directed our development financial institutions to engage these development partners and negotiate concessions to ease the pains of the borrowers.

    54. For the most vulnerable in our society, I have directed that the conditional cash transfers for the next two months be paid immediately. Our Internally displaced persons will also receive two months of food rations in the coming weeks.

    55. We also call on all Nigerians to take personal responsibility to support those who are vulnerable within their communities, helping them with whatever they may need.

    56. As we all pray for the best possible outcome, we shall continue planning for all eventualities.

    57. This is why I directed that all Federal Government Stadia, Pilgrims camps and other facilities be converted to isolation centers and makeshift hospitals.

    58. My fellow Nigerians, as a Government, we will avail all necessary resources to support the response and recovery. We remain committed to do whatever it takes to confront COVID-19 in our country.

    59. We are very grateful to see the emerging support of the private sector and individuals to the response as well as our development partners.

    60. At this point, I will ask that all contributions and donations be coordinated and centralized to ensure efficient and impactful spending. The Presidential Task Force remains the central coordinating body on the COVID-19 response.

    61. I want to assure you all that Government Ministries, Departments and Agencies with a role to play in the outbreak response are working hard to bring this virus under control.

    62. Every nation in the world is challenged at this time. But we have seen countries where citizens have come together to reduce the spread of the virus.

    63. I will therefore implore you again to strictly comply with the guidelines issued and also do your bit to support Government and the most vulnerable in your communities.

    64. I will take this opportunity to thank all our public health workforce, health care workers, port health authorities and other essential staff on the frontlines of the response for their dedication and commitment. You are true heroes.

    65. I thank you all for listening. May God continue to bless and protect us all.

    President Muhammadu Buhari

    Views: 0